Hi hoops. We are awaiting the 10 q quarterly repor
Post# of 36537
Joe just gave an update on the ngio shares in the last CC. I doubt we hear anything substantial until they formalize whatever merger they were working on and then begin trading. I hope we do get updates about who actually is the CEO of NuGenImmuno etc. As well as get the new study listed on clinicaltrials.org and recruiting.